Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS INC | $7.68 | $4.35 | 76.49% | 128.00x | -23.53x | 5.89x | 7.02x | 0.66x | -$150.00k | -0.03% | $106.03M | 1.19 | $708.55M | 55.18 | ||
| SLNO | SOLENO THERAPEUTICS INC | $52.82 | $40.51 | 30.39% | 132.05x | 13.31x | 14.10x | 6.06x | 0.48x | $46.73M | 1.74% | $450.12M | 8.86 | $2.71B | 93.45 | ||
| ADMA | ADMA BIOLOGICS INC | $10.25 | $11.42 | -10.26% | 16.53x | 10.52x | 4.79x | 5.11x | 0.44x | $27.82M | 1.14% | $477.32M | 2.00 | $2.43B | 12.26 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $309.49 | $93.69 | 230.32% | 70.98x | 45.34x | 9.59x | 38.42x | 1.52x | $641.34M | 1.56% | $1.08B | 8.09 | $42.58B | 46.06 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.17 | $18.31 | -44.46% | 7.26x | 20.51x | 5.28x | 3.86x | 0.33x | -$1.99M | -0.35% | $154.66M | 2.80 | $597.90M | 6.02 | ||
| CORT | CORCEPT THERAPEUTICS INC | $46.52 | $20.28 | 129.35% | 48.97x | 85.74x | 6.35x | 7.64x | 1.06x | $141.79M | 2.93% | $647.81M | 6.24 | $4.83B | 106.94 | ||
| KRYS | KRYSTAL BIOTECH INC | $262.26 | $106.68 | 145.84% | 37.04x | 33.68x | 19.51x | 6.29x | 1.32x | $189.35M | 2.49% | $1.22B | 42.14 | $7.18B | 36.63 | ||
| HALO | HALOZYME THERAPEUTICS INC | $63.66 | $68.95 | -7.67% | 24.11x | 7.79x | 5.46x | 153.91x | 0.40x | $644.59M | 8.45% | $48.81M | 0.41 | $9.52B | 16.61 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.73 | $3.29 | 43.81% | 21.50x | 17.01x | 2.89x | 4.95x | 0.78x | $13.21M | 3.53% | $76.53M | 0.97 | $316.81M | 16.13 | ||
| RPRX | ROYALTY PHARMA PLC | $50.09 | $40.96 | 22.29% | 27.98x | 9.69x | 9.05x | 2.97x | 0.55x | $2.22B | 10.31% | $9.71B | 22.60 | $37.23B | 34.51 | ||
| VCEL | VERICEL CORP | $34.73 | $8.31 | 318.10% | 105.24x | 78.72x | 6.33x | 4.97x | 1.84x | $24.75M | 1.42% | $354.64M | 7.05 | $1.76B | 50.40 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $31.26 | $35.46 | -11.84% | 11.33x | 8.52x | 2.07x | 2.08x | 0.53x | $347.89M | 19.36% | $870.22M | 15.14 | $1.22B | 4.78 | ||
| MNKD | MANNKIND CORP | $2.83 | $1.05 | 168.84% | 141.50x | 325.29x | 2.48x | -17.09x | 1.03x | $13.69M | 1.59% | -$51.02M | -0.17 | $1.40B | 26.49 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $53.78 | $16.32 | 229.52% | 54.88x | 48.75x | 5.46x | 6.83x | 1.68x | $164.23M | 3.99% | $605.69M | 7.92 | $3.96B | 35.49 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $53.91 | $46.28 | 16.49% | 29.62x | 12.33x | 3.21x | 1.70x | 0.51x | $724.96M | 7.01% | $6.09B | 31.74 | $9.65B | 16.85 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $40.95 | $4.97 | 723.62% | 227.50x | -34.71x | 5.15x | 14.14x | 3.53x | $45.01M | 0.87% | $370.15M | 2.93 | $5.24B | 74.88 | ||
| EXEL | EXELIXIS INC | $44.46 | $34.65 | 28.32% | 15.44x | 13.91x | 5.20x | 5.34x | 0.80x | $875.84M | 7.25% | $2.16B | 7.96 | $11.24B | 11.30 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $229.45 | $107.61 | 113.22% | 35.63x | 23.93x | 16.55x | 4.50x | 1.09x | $48.09M | 1.08% | $1.02B | 52.60 | $4.85B | 24.33 | ||
| TECH | BIO-TECHNE CORP | $55.32 | $15.28 | 262.08% | 106.38x | 27.35x | 7.09x | 4.30x | 1.53x | $223.02M | 2.59% | $2.01B | 12.90 | $8.83B | 39.01 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $707.06 | $434.16 | 62.86% | 16.61x | 15.08x | 4.93x | 2.36x | 1.20x | $4.11B | 5.59% | $31.42B | 302.15 | $73.87B | 12.86 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $28.13 | $14.62 | 92.40% | 16.07x | 14.67x | 5.84x | 3.60x | 1.88x | $208.61M | 6.06% | $954.27M | 7.80 | $2.73B | 8.48 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $427.38 | $183.41 | 133.02% | 27.64x | 21.94x | 9.11x | 5.82x | 1.48x | $3.19B | 2.92% | $18.67B | 73.00 | $105.33B | 21.64 | ||
| MDXG | MIMEDX GROUP INC | $3.36 | $2.36 | 42.51% | 16.00x | 29.95x | 1.28x | 2.06x | 0.95x | $69.36M | 13.90% | $242.94M | 1.64 | $358.28M | 6.58 | ||
| VCYT | VERACYTE INC | $32.92 | $10.08 | 226.44% | 39.19x | 31.06x | 5.00x | 2.00x | 2.05x | $126.63M | 4.89% | $1.31B | 16.67 | $2.29B | 24.74 | ||
| UTHR | UNITED THERAPEUTICS CORP | $571.35 | $263.00 | 117.25% | 18.96x | 19.55x | 7.95x | 3.53x | 1.97x | $1.04B | 4.11% | $7.10B | 160.19 | $23.48B | 12.91 | ||
| INCY | INCYTE CORP | $95.27 | $64.35 | 48.05% | 13.07x | 12.31x | 3.54x | 3.38x | 1.32x | $1.45B | 7.64% | $5.62B | 28.21 | $15.60B | 8.34 | ||
| XOMA | XOMA ROYALTY CORP | $40.94 | $9.83 | 316.53% | 26.76x | 83.62x | 9.48x | 5.81x | 9.10x | -$1.83M | -0.37% | $83.94M | 6.95 | $530.62M | 15.30 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.51 | $3.84 | 95.70% | 12.11x | 18.41x | 1.64x | 2.93x | 5.36x | $41.73M | 11.11% | $130.34M | 2.61 | $378.90M | 7.10 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.